|
Index of reports
> Life Threatening Events (14)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Thalomid (Thalidomide) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Thalomid side effects in female
Reported by a physician from United States on 2012-07-26
Patient: female
Reactions: Brain Neoplasm Malignant
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Thalomid
Dosage: 50 milligram
Administration route: Oral
Start date: 2010-07-01
Thalomid
Dosage: 50 milligram
Administration route: Oral
Start date: 2012-05-16
End date: 2012-06-12
Other drugs received by patient: Fenofibrate; Lapatinib; Celebrex; Keppra; Levothyroxine Sodium
Possible Thalomid side effects in male
Reported by a physician from Belgium on 2012-07-13
Patient: male
Reactions: Prostate Cancer
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Dexamethasone
Indication: Multiple Myeloma
Start date: 2010-01-01
End date: 2010-12-01
Revlimid
Administration route: Oral
Indication: Multiple Myeloma
Thalomid
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-01-01
End date: 2010-12-01
Possible Thalomid side effects in male
Reported by a physician from Belgium on 2012-07-12
Patient: male
Reactions: Prostate Cancer
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Dexamethasone Sodium Posphate
Indication: Multiple Myeloma
Start date: 2010-01-01
End date: 2010-12-01
Revlimid
Administration route: Oral
Indication: Multiple Myeloma
Thalomid
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-01-01
End date: 2010-12-01
Possible Thalomid side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-06
Patient: female
Reactions: General Physical Health Deterioration
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Thalomid
Dosage: 50 milligram
Administration route: Oral
Start date: 2012-05-16
End date: 2012-06-12
Thalomid
Dosage: 50 milligram
Administration route: Oral
Start date: 2010-07-01
Possible Thalomid side effects in male
Reported by a physician from United States on 2012-05-08
Patient: male, weighing 84.0 kg (184.8 pounds)
Reactions: Graft Versus Host Disease, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Thalomid
Dosage: 200 milligram
Administration route: Oral
Start date: 2012-02-01
Thalomid
Dosage: 400 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-10-01
Other drugs received by patient: Vfend; Flagyl
Possible Thalomid side effects in male
Reported by a pharmacist from United States on 2012-04-27
Patient: male
Reactions: Graft Versus Host Disease, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Thalomid
Dosage: 200 milligram
Administration route: Oral
Start date: 2012-02-01
Thalomid
Dosage: 400 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-10-01
Possible Thalomid side effects in female
Reported by a physician from United States on 2012-04-17
Patient: female
Reactions: Thrombosis, Renal Failure, Neuropathy Peripheral
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Thalomid
Dosage: 100 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-02-01
Thalomid
Dosage: 150 milligram
Administration route: Oral
Start date: 2011-04-01
End date: 2011-01-01
Possible Thalomid side effects in male
Reported by a physician from United States on 2012-01-20
Patient: male, weighing 88.5 kg (194.8 pounds)
Reactions: Myelodysplastic Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Thalomid
Possible Thalomid side effects in female
Reported by a physician from Australia on 2012-01-19
Patient: female
Reactions: Haemorrhage, Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Thalomid
Dosage: 50 milligram
Administration route: Oral
Start date: 2012-01-01
Thalomid
Dosage: 200 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-12-01
Possible Thalomid side effects in male
Reported by a health professional (non-physician/pharmacist) from Canada on 2011-12-27
Patient: male
Reactions: Life Support
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Thalomid
Possible Thalomid side effects in male
Reported by a physician from United States on 2011-12-05
Patient: male
Reactions: Multiple Myeloma
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Revlimid
Thalomid
Dosage: 50 milligram
Administration route: Oral
Start date: 2011-04-07
End date: 2011-10-12
Thalomid
Dosage: 100 milligram
Administration route: Oral
Start date: 2010-11-05
Other drugs received by patient: Neurontin; Lortab; Lisinopril
Possible Thalomid side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-01
Patient: male
Reactions: Subdural Haematoma
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Thalomid
Possible Thalomid side effects in male
Reported by a physician from United States on 2011-11-23
Patient: male
Reactions: Multiple Myeloma
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Revlimid
Thalomid
Dosage: 50 milligram
Administration route: Oral
Start date: 2010-11-05
End date: 2011-11-01
Other drugs received by patient: Lisinopril; Neurontin; Lortab
Possible Thalomid side effects in female
Reported by a physician from Canada on 2011-11-14
Patient: female, weighing 71.0 kg (156.2 pounds)
Reactions: Drug Hypersensitivity, Posterior Reversible Encephalopathy Syndrome, Herpes Zoster Disseminated
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Thalomid
Other drugs received by patient: Pamidronate Disodium; Dilantin; Hydromorphone HCL; Hydromorphone HCL; Valtrate; Lyrica; Acyclovir; Azithromycin; Meropenem; Docusate Sodium; Cefotaxime
|
